[Orbital epithelioid hemangioma: a case report].

J Fr Ophtalmol

Service de médecine interne, hôpital Habib Thameur, 8, rue Ali Ben Ayed, Montfleury, 1008 Tunis, Tunisie.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfo.2014.01.017DOI Listing

Publication Analysis

Top Keywords

[orbital epithelioid
4
epithelioid hemangioma
4
hemangioma case
4
case report]
4
[orbital
1
hemangioma
1
case
1
report]
1

Similar Publications

Background: Perivascular epithelioid cell tumors (PEComas) rarely appear in the head and neck region. This case report describes two transcription factor E3 (TFE3)-rearranged PEComa cases, consisting of one in the orbit and one in the nasal cavity.

Case Presentation: Both cases demonstrated sheet-like or focal nested architecture and comprised epithelioid cells with abundant clear to eosinophilic cytoplasm and vascular stroma.

View Article and Find Full Text PDF

Epithelioid haemangioendothelioma (EHE) is a rare vascular neoplasm characterised by proliferation of vascular endothelial and pre-endothelial cells. The prevalence is less than one in a million people. It is principally observed in the soft tissues of the extremities but can also occur in the bone, brain, liver, lung and lymph nodes.

View Article and Find Full Text PDF

TFE3 rearrangements characterize histogenetically, topographically, and biologically diverse neoplasms. Besides being a universal defining feature in alveolar soft part sarcoma (ASPS) and clear cell stromal tumor of the lung, TFE3 fusions have been reported in subsets of renal cell carcinoma, perivascular epithelioid cell tumor (PEComa), epithelioid hemangioendothelioma and ossifying fibromyxoid tumors. TFE3 -related neoplasms are rare in the head and neck and may pose diagnostic challenges.

View Article and Find Full Text PDF

MN1 fusion is emerging as oncogenic in soft-tissue tumors. Here, we provided detailed clinicopathological documentation of a tumor with MN1::TAF3 fusion. The tumor developed on the face of an 8-year-old boy and did not recur or metastasize for 5 years after surgery without adjuvant therapy.

View Article and Find Full Text PDF

Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma.

Asia Pac J Ophthalmol (Phila)

October 2024

Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, PR China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai 200011, PR China. Electronic address:

Article Synopsis
  • The study aimed to identify risk factors for poor prognosis in uveal melanoma among a Chinese population, focusing on the genetic markers monosomy 3, 8q gain, and EZH2 staining.
  • Examining 89 patient cases from 2012 to 2021, researchers conducted immunohistochemical analysis and evaluated survival rates using statistical methods like Kaplan-Meier and Cox regression.
  • Key findings indicated that factors such as age, tumor size, stage, and the presence of 8q gain and high EZH2 expression were linked to higher rates of distant metastasis, while monosomy 3 showed no significant association in this study.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!